MUC5B and idiopathic pulmonary fibrosis: For early asymptomatic f-IPF, the increased MUC5B levels can appear years before the symptoms of PF, and it can be detected in patients with mild PF 165; the variant can serve as an effective new molecular target for intervention during the early stages of IPF.